Nastech Pharmaceutical Company Inc.
<b>Name change to MDRNA, Inc.</b>
3450 Monte Villa Parkway
Bothell
Washington
98021
United States
Tel: 425-908-3600
Fax: 425-908-3650
Website: http://www.nastech.com/
Email: nastech@nastech.com
105 articles about Nastech Pharmaceutical Company Inc.
-
Nastech Pharmaceutical Company Inc. Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
6/11/2008
-
Nastech Pharmaceutical Company Inc. Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
6/9/2008
-
Nastech Pharmaceutical Company Inc. Announces First Quarter 2008 Financial Results
5/9/2008
-
Nastech Pharmaceutical Company Inc. to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008
5/2/2008
-
Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering
4/25/2008
-
Nastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board
3/27/2008
-
Nastech Pharmaceutical Company Inc. to Present RNAi Data
3/25/2008
-
Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)
3/24/2008
-
Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company Inc.
3/19/2008
-
Nastech Pharmaceutical Company Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3/18/2008
-
Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum
3/13/2008
-
Nastech Pharmaceutical Company Inc. Completes Key RNAi Patent Filings
3/11/2008
-
Nastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi Subsidiary
3/7/2008
-
Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
3/3/2008
-
Nastech Pharmaceutical Company Inc. to Cut 50 Jobs
2/13/2008
-
Nastech Pharmaceutical Company Inc. Appoints MDRNA, Inc. Directors Strategic Advisory Board
2/5/2008
-
Nastech Pharmaceutical Company Inc. Receives Notice of Allowance for U.S. Patent Related to Methods for Identifying Cell-Specific Targeting Peptides
1/8/2008
-
Nastech Pharmaceutical Company Inc. Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
1/8/2008
-
Nastech Pharmaceutical Company Inc. Names Interim CFO
1/7/2008
-
Nastech Pharmaceutical Company Inc. Announces Promotion of Gordon Brandt, M.D. to President
12/20/2007